The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 84 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R15 CA256838
NCI NIH HHS
Grant: R00 CA140948
NCI NIH HHS
Grant: R03 CA208384
NIA NIH HHS
Grant: R21 AG081896
National Institutes of Health
Grant: 5R00CA140948-04
Molecular mechanisms of chemoresistance in breast cancer
National Institutes of Health
Grant: 1R15CA256838-01
Role of CD36 and diet-derived fatty acids in breast cancer
National Institutes of Health
Grant: 5R21AG081896-02
Role of the ubiquitin E3 ligase HUWE1 in age-associated nonalcoholic fatty liver disease
National Institutes of Health
Grant: 7R03CA208384-02
Role of CD36 in Breast Tumors
FWCI
8.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals